https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:29943 Wed 11 Apr 2018 14:19:55 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37846 Tue 18 May 2021 16:44:03 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35487 Thu 30 Jan 2020 13:53:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:25146 Sat 24 Mar 2018 07:17:10 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:27084 Mon 23 Sep 2019 13:09:46 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30387 Mon 23 Sep 2019 13:02:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30384 Fri 30 Aug 2019 12:46:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:31493 2 = 0.45). Analysis of HRV parameters revealed significant reduction in both RMSSD (p = 0.02, t = 2.62, η2 = 0.43) and SDRR (p = 0.01, t = 2.90, η2 = 0.45) in the forward ride; no such changes were found in the backward ride. We also found that amplitude of phasic changes in forehead skin conductance increased significantly in both ride directions. This increase however was significantly lower (p<0.05) in backward ride when compared to the forward ride. When assessed immediately post-ride, subjects reported significantly lower (p = 0.04) subjective symptom intensity after the reverse ride compared to the forward ride. We conclude that the direction of visual flow has a significant effect on the symptoms reported by the subjects and on the physiological changes during cybersickness.]]> Fri 21 Jun 2019 18:10:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35456 Fri 16 Aug 2019 15:05:59 AEST ]]>